GB/T 16886.4-2022

Active

Biological evaluation of medical devices—Part 4: Selection of tests for interactions with blood

医疗器械生物学评价 第4部分:与血液相互作用试验选择

Standard Type
GBT
ICS
11.040.01
CCS
C30
Status
Active
Issue Date
2022-04-15
Implementation
2023-05-01
Centralized Committee
国家药监局
Issuing Authority
国家市场监督管理总局、中国国家标准化管理委员会

Application Summary AI generated

This standard specifies the selection criteria for evaluating the interactions between medical devices and blood, including tests for hemolysis, thrombosis, and complement activation. It is applied in the biological safety assessment of blood-contacting medical devices, such as catheters, stents, and hemodialyzers, during preclinical testing and regulatory approval processes. The standard guides manufacturers and testing laboratories in China to choose appropriate in vitro and in vivo assays based on device type and contact duration.

Related Standards

Transparency note: The application summary and key sentences on this page were automatically generated by AI from the standard's original text. This content has not been human-verified and should not be used for compliance or regulatory purposes. Always refer to the official standard document from the issuing authority.